Back to results
US 2026/0103445 A1Published application
Compositions Comprising a Retinoid X Receptor (RXR) Agonist, a Retinoic Acid Receptor (RAR) Agonist, or a Dual RXR/RAR Agonist
AssigneeArizona Board of Regents on behalf of Arizona State University
InventorsCarl Wagner, Pamela Marshall, Peter Jurutka
Life of this patent
Estimating the term…
Abstract
The present invention relates to compositions comprising an RXR agonist, an RAR agonist, or a dual RXR/RAR agonist. The present invention further relates to methods of using the agonist compositions for treating or preventing dementia and cancer. In some embodiments, the dementia comprises Alzheimer's disease. In some embodiments, the cancer comprises leukemia.
Claims21
-7. (canceled)
A compound of formula (4), or a pharmaceutically acceptable salt, solvate, hydrate or stereoisomer thereof:
- wherein X40-X42 are each independently N or CR46, and at least one of X40-X42 is CR46;
- wherein R40-R44 are each independently hydrogen, —C1-C6 alkyl, or —OR47;
- wherein R45 and R46 are each independently selected from the group consisting of:
- hydrogen, halogen, —OH, and —CO2H;
- wherein each R47 is independently —C1-C6 alkyl;
- and
- wherein n is 0 or 1.
4 more elements
Dependencies are inferred from the claim text.